DK0812320T3 - Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse - Google Patents
Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelseInfo
- Publication number
- DK0812320T3 DK0812320T3 DK96904993T DK96904993T DK0812320T3 DK 0812320 T3 DK0812320 T3 DK 0812320T3 DK 96904993 T DK96904993 T DK 96904993T DK 96904993 T DK96904993 T DK 96904993T DK 0812320 T3 DK0812320 T3 DK 0812320T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- sec
- peak
- pyrethanide
- amorphous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Glass Compositions (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03321595A JP3532987B2 (ja) | 1995-02-22 | 1995-02-22 | 新規な無晶形ピレタニドおよびその製造方法 |
JP03321695A JP3532988B2 (ja) | 1995-02-22 | 1995-02-22 | ピレタニドの新規な結晶多形およびその製造方法 |
PCT/IB1996/000254 WO1996026197A1 (en) | 1995-02-22 | 1996-02-12 | Amorphous piretanide, piretanide polymorphs, process for their preparation and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0812320T3 true DK0812320T3 (da) | 2003-04-14 |
Family
ID=26371876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96904993T DK0812320T3 (da) | 1995-02-22 | 1996-02-12 | Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse |
Country Status (15)
Country | Link |
---|---|
US (1) | US6096779A (da) |
EP (1) | EP0812320B1 (da) |
KR (1) | KR100419355B1 (da) |
CN (1) | CN1072215C (da) |
AT (1) | ATE194607T1 (da) |
BR (1) | BR9607295A (da) |
CA (1) | CA2213693C (da) |
DE (1) | DE69609314T2 (da) |
DK (1) | DK0812320T3 (da) |
ES (1) | ES2150105T3 (da) |
GR (1) | GR3034605T3 (da) |
HK (1) | HK1006783A1 (da) |
MX (1) | MX9706339A (da) |
PT (1) | PT812320E (da) |
WO (1) | WO1996026197A1 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW403740B (en) | 1997-06-10 | 2000-09-01 | Novartis Ag | Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide |
DE10013289A1 (de) * | 2000-03-17 | 2001-09-20 | Knoll Ag | Torasemid enthaltende pharmazeutische Zubereitungen |
HRP20000162B1 (en) | 2000-03-20 | 2004-06-30 | Pliva D D | Amorphous torasemide modification |
PT2767539T (pt) | 2002-05-16 | 2017-08-28 | Janssen Sciences Ireland Uc | Formas pseudopolimórficas de um inibidor de protease de hiv |
WO2005067887A2 (en) * | 2004-03-24 | 2005-07-28 | Actavis Group | Formulations of ramipril |
GB2431579A (en) * | 2005-10-28 | 2007-05-02 | Arrow Int Ltd | Ramipril formulations |
US20070098782A1 (en) * | 2005-10-28 | 2007-05-03 | Selamine Limited | Ramipril Formulation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2419970C3 (de) * | 1974-04-25 | 1980-06-12 | Hoechst Ag, 6000 Frankfurt | 3-<l-Pyrrolidinyl)-4-phenoxy-5sulfamoylbenzoesäure und Verfahren zu ihrer Herstellung |
JPS5283547A (en) * | 1976-01-01 | 1977-07-12 | Hoechst Ag | Tertiary cyclic amine |
DE2655331A1 (de) * | 1976-12-07 | 1978-06-08 | Hoechst Ag | Zubereitungsformen von 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoesaeure und verfahren zu ihrer herstellung |
ES2025085B3 (es) * | 1986-04-29 | 1992-03-16 | Hoechst-Roussel Pharmaceuticals Incorporated | Una estructura laminar para la administracion de un producto quimico a una velocidad de liberacion controlada. |
EP0465841A3 (en) * | 1990-06-13 | 1992-10-14 | Hoechst Aktiengesellschaft | Quick acting pharmaceutical inhalation forms of diuretics |
JPH05230044A (ja) * | 1992-02-21 | 1993-09-07 | Hoechst Japan Ltd | ピレタニドの新規な結晶多形 |
-
1996
- 1996-02-12 DK DK96904993T patent/DK0812320T3/da active
- 1996-02-12 ES ES96904993T patent/ES2150105T3/es not_active Expired - Lifetime
- 1996-02-12 DE DE69609314T patent/DE69609314T2/de not_active Expired - Lifetime
- 1996-02-12 CA CA002213693A patent/CA2213693C/en not_active Expired - Lifetime
- 1996-02-12 WO PCT/IB1996/000254 patent/WO1996026197A1/en active IP Right Grant
- 1996-02-12 BR BR9607295A patent/BR9607295A/pt not_active IP Right Cessation
- 1996-02-12 AT AT96904993T patent/ATE194607T1/de active
- 1996-02-12 EP EP96904993A patent/EP0812320B1/en not_active Expired - Lifetime
- 1996-02-12 PT PT96904993T patent/PT812320E/pt unknown
- 1996-02-12 US US08/894,412 patent/US6096779A/en not_active Expired - Lifetime
- 1996-02-12 CN CN96192081A patent/CN1072215C/zh not_active Expired - Lifetime
- 1996-02-12 KR KR1019970705772A patent/KR100419355B1/ko not_active IP Right Cessation
-
1997
- 1997-08-20 MX MX9706339A patent/MX9706339A/es unknown
-
1998
- 1998-06-18 HK HK98105624A patent/HK1006783A1/xx not_active IP Right Cessation
-
2000
- 2000-10-12 GR GR20000402289T patent/GR3034605T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
MX9706339A (es) | 1998-07-31 |
EP0812320A1 (en) | 1997-12-17 |
CA2213693A1 (en) | 1996-08-29 |
KR100419355B1 (ko) | 2004-06-04 |
DE69609314D1 (de) | 2000-08-17 |
US6096779A (en) | 2000-08-01 |
GR3034605T3 (en) | 2001-01-31 |
WO1996026197A1 (en) | 1996-08-29 |
ES2150105T3 (es) | 2000-11-16 |
CN1072215C (zh) | 2001-10-03 |
DE69609314T2 (de) | 2001-06-13 |
EP0812320B1 (en) | 2000-07-12 |
ATE194607T1 (de) | 2000-07-15 |
PT812320E (pt) | 2000-12-29 |
CN1175948A (zh) | 1998-03-11 |
HK1006783A1 (en) | 1999-03-19 |
BR9607295A (pt) | 1997-11-25 |
CA2213693C (en) | 2008-04-15 |
KR19980702374A (ko) | 1998-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001520162A5 (da) | ||
NO306346B1 (no) | N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat | |
HU9503986D0 (en) | Perhydroisoindole derivatives as p substance antagonists | |
EG20218A (en) | Process for preparing of substituted 3 aminoquinuclidines | |
CA2075173A1 (en) | Compounds and methods for inhibition of hiv and related viruses | |
PE96999A1 (es) | 1-(4-carbazoliloxi)-3-[2-(2-metoxifenoxi)etilamino]-2-propanol termodinamicamente estable, proceso para su preparacion y composiciones farmaceuticas que contienen dicho compuesto | |
MX13270A (es) | Procedimiento para la preparacion de derivados de 4-aminopiridina | |
DK0812320T3 (da) | Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse | |
HU9602413D0 (en) | Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same | |
AU1027992A (en) | Substituted 1,2,3,4-tetrahydrocyclopent(b)indoles, 1,2,3,3a,4,8a-hexahydrocyclopent(b)indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments | |
FI92320C (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi | |
NO975921L (no) | Fremstilling av bicykloheksanderivater | |
AU4442389A (en) | 1,2,3,4-tetrahydro-1,9-acridinediamines, a process for their preparation and their use as medicaments | |
HUT77768A (hu) | N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk | |
YU6087A (en) | Process for obtaining 2-benzimidazole-ilalkylthiosulphinyl or sulphonyl derivatives | |
IL108290A0 (en) | Pyrrolidine derivatives, their preparation and medicaments containing them | |
ES2138734T3 (es) | Procedimiento para la preparacion de derivados de 1-(3-trialquilsililfenil)-2,2,2-trifluormetil etanona. | |
PL325638A1 (en) | Substituted 2-phenylpyridines | |
IL117083A0 (en) | Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical agents containing these compounds | |
AU7230894A (en) | Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases | |
AU2796695A (en) | Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders | |
RU94026827A (ru) | Способ получения диорганилциклосилоксанов | |
CA2614979A1 (en) | Piretanide polymorph, process for its preparation and its use |